Showing results (881-890 of 3,172) with videos related to

Sort By:
Pageof 318
Translational Oncology|April 2, 2013
Imatinib and Dasatinib Inhibit Hemangiosarcoma and Implicate PDGFR-β and Src in Tumor GrowthErin B Dickerson, Kevin Marley, Wade Edris, et al.
Translational Oncology|April 2, 2013
Radiosensitization of Glioblastoma Cell Lines by the Dual PI3K and mTOR Inhibitor NVP-BEZ235 Depends on Drug-Irradiation ScheduleSebastian Kuger, Dorothea Graus, Rico Brendtke, et al.
Translational Oncology|April 2, 2013
FAK Inhibition Decreases Hepatoblastoma Survival Both In Vitro and In VivoLauren A Gillory, Jerry E Stewart, Michael L Megison, et al.
Translational Oncology|June 5, 2013
The Histone Methyltransferase EZH2 Mediates Tumor Progression on the Chick Chorioallantoic Membrane Assay, a Novel Model of Head and Neck Squamous Cell CarcinomaMin Liu, Christina Springstead Scanlon, Rajat Banerjee, et al.
Translational Oncology|June 5, 2013
Circulating methylated septin 9 nucleic Acid in the plasma of patients with gastrointestinal cancer in the stomach and colonHye Seung Lee, Sang Mee Hwang, Taek Soo Kim, et al.
Translational Oncology|June 5, 2013
RASSF1A Promoter Methylation Levels Positively Correlate with Estrogen Receptor Expression in Breast Cancer PatientsViera Kajabova, Bozena Smolkova, Iveta Zmetakova, et al.
Translational Oncology|June 5, 2013
Evaluation of potentially predictive markers for anti-angiogenic therapy with sunitinib in recurrent ovarian cancer patientsDirk O Bauerschlag, Felix Hilpert, Werner Meier, et al.
Translational Oncology|June 5, 2013
Galanin has tumor suppressor activity and is frequently inactivated by aberrant promoter methylation in head and neck cancerKiyoshi Misawa, Takeharu Kanazawa, Yuki Misawa, et al.
Translational Oncology|June 5, 2013
MRI detection of nonproliferative tumor cells in lymph node metastases using iron oxide particles in a mouse model of breast cancerVasiliki Economopoulos, Yuhua Chen, Catherine McFadden, et al.
Translational Oncology|December 4, 2009
Magnetic resonance assessment of response to therapy: tumor change measurement, truth data and error sourcesEdward F Jackson, Daniel P Barboriak, Luc M Bidaut, et al.
Pageof 318